What is NDC 16571-326?

16571-326 is the product NDC for Aminocaproic Acid, Aminocaproic acid 500 mg/1 tablet, listed with the FDA by RISING PHARMA HOLDINGS, INC.. It has 1 package NDC, shown above in 10- and 11-digit form.

RISING PHARMA HOLDINGS, INC., NDC labeler code 16571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Aminocaproic Acid?

35 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Aminocaproic Acid NDC 16571-326 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)16571-326Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16571-0326Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16571-326-03	1657103260316571032603	30 TABLET in 1 BOTTLE (16571-326-03)Marketed from Sep 20, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aminocaproic Acid
Generic name (nonproprietary): aminocaproic acid
Active ingredients: Aminocaproic acid — 500 mg/1
Dosage form: Tablet
Route: Oral
Labeler: RISING PHARMA HOLDINGS, INC.NDC labeler code 16571
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213944
Marketing start: Sep 20, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Fibrinolysis (Physiologic effect)
Identifiers: Product ID 16571-326_c9542474-b523-4bf0-966e-3ce9fe35a0a2SPL ID c9542474-b523-4bf0-966e-3ce9fe35a0a2
Pharmacologic class: Antifibrinolytic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416571032603 followed by a unit qualifier and the quantity

Package 16571-0326-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 16571-326

What is NDC 16571-326?: 16571-326 is the product NDC for Aminocaproic Acid, Aminocaproic acid 500 mg/1 tablet, listed with the FDA by RISING PHARMA HOLDINGS, INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Aminocaproic Acid.
What is the active ingredient?: Aminocaproic acid.
Who is the labeler?: RISING PHARMA HOLDINGS, INC., NDC labeler code 16571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Aminocaproic Acid?: 35 other product NDCs are listed under this name. See all Aminocaproic Acid NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Aminocaproic Acid NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Aminocaproic Acid	Aminocaproic acid 1000 mg/1	TabletOral	RISING PHARMA HOLDINGS, INC.	16571-327	16571-0327-03
Aminocaproic Acid	Aminocaproic acid .25 g/mL	SolutionOral	Florida Pharmaceutical Products, LLC	71921-175	71921-0175-08
Aminocaproic Acid	Aminocaproic acid .25 g/mL	SolutionOral	Apozeal Pharmaceuticals Inc.	83745-294	83745-0294-08
Aminocaproic acid	Aminocaproic acid .25 g/mL	SolutionOral	Novadoz Pharmaceuticals LLC	72205-032	72205-0032-7172205-0032-72
Aminocaproic Acid	Aminocaproic acid .25 g/mL	SolutionOral	Vitruvias Therapeutics	69680-114	69680-0114-08
Aminocaproic acid	Aminocaproic acid 1000 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-286	72205-0286-30
Aminocaproic Acid	Aminocaproic acid 500 mg/1	TabletOral	American Health Packaging	60687-739	60687-0739-25
Aminocaproic Acid	Aminocaproic acid 500 mg/1	TabletOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-798	24658-0798-30
Aminocaproic Acid	Aminocaproic acid 1000 mg/1	TabletOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-799	24658-0799-30
Aminocaproic Acid	Aminocaproic acid .25 g/mL	SolutionOral	Camber Pharmaceuticals, Inc.	31722-035	31722-0035-23

All 36 Aminocaproic Acid NDCs

Other NDCs under ANDA 213944

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213944
Product	Strength	Form · route	Labeler	Product NDC
Aminocaproic Acid	Aminocaproic acid 1000 mg/1	TabletOral	RISING PHARMA HOLDINGS, INC.	16571-327